Total Payments
$2,951
2024 Payments
$495.92
Companies
33
Transactions
185
Medicare Patients
669
Medicare Billing
$90,085
Payment Breakdown by Category
Food & Beverage$2,926 (99.1%)
Education$25.60 (0.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,926 | 183 | 99.1% |
| Education | $25.60 | 2 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $555.75 | 38 | $0 (2024) |
| Lilly USA, LLC | $457.29 | 29 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $250.84 | 18 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $221.03 | 13 | $0 (2024) |
| Allergan Inc. | $206.05 | 7 | $0 (2019) |
| Amgen Inc. | $154.41 | 10 | $0 (2024) |
| ARBOR PHARMACEUTICALS, INC. | $104.99 | 8 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $104.86 | 7 | $0 (2024) |
| Shire North American Group Inc | $97.40 | 6 | $0 (2018) |
| Jazz Pharmaceuticals Inc. | $93.16 | 6 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $495.92 | 28 | Novo Nordisk Inc ($109.69) |
| 2023 | $355.25 | 24 | Novo Nordisk Inc ($127.55) |
| 2022 | $203.83 | 12 | Novo Nordisk Inc ($43.46) |
| 2021 | $128.75 | 9 | Lilly USA, LLC ($42.95) |
| 2020 | $437.96 | 29 | Lilly USA, LLC ($125.93) |
| 2019 | $416.94 | 20 | Allergan Inc. ($147.39) |
| 2018 | $428.45 | 29 | Novo Nordisk Inc ($138.68) |
| 2017 | $484.18 | 34 | Merck Sharp & Dohme Corporation ($98.04) |
All Payment Transactions
185 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $17.97 | General |
| Category: Cardiology | ||||||
| 09/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: Inflammation | ||||||
| 09/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Diabetes | ||||||
| 09/03/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: Endocrinology | ||||||
| 08/29/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: Endocrinology | ||||||
| 08/19/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: Diabetes | ||||||
| 08/15/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.16 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/13/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 08/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: DIABETES | ||||||
| 08/06/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Inflammation | ||||||
| 07/16/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.10 | General |
| Category: Respiratory | ||||||
| 07/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/02/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: Diabetes | ||||||
| 06/25/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 06/24/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: Diabetes | ||||||
| 05/20/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: Inflammation | ||||||
| 05/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: DIABETES | ||||||
| 05/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/13/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/01/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: Diabetes | ||||||
| 04/04/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Obesity | ||||||
| 02/26/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: Diabetes | ||||||
| 02/21/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: Diabetes | ||||||
| 02/20/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Inflammation | ||||||
| 01/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 498 | 1,078 | $267,737 | $66,736 |
| 2022 | 6 | 171 | 267 | $88,565 | $23,350 |
Total Patients
669
Total Services
1,345
Medicare Billing
$90,085
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 144 | 280 | $120,633 | $30,786 | 25.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 152 | 329 | $101,188 | $25,487 | 25.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 46 | 46 | $25,259 | $5,049 | 20.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 29 | 29 | $12,481 | $2,804 | 22.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 17 | 17 | $5,358 | $1,878 | 35.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 41 | 59 | $2,029 | $542.19 | 26.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 11 | 12 | $300.00 | $114.24 | 38.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 20 | 24 | $220.00 | $52.80 | 24.0% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 38 | 282 | $268.50 | $22.60 | 8.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 51 | 81 | $38,028 | $9,832 | 25.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 65 | 114 | $37,335 | $9,749 | 26.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 16 | 16 | $5,600 | $1,909 | 34.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 14 | 14 | $6,230 | $1,567 | 25.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 13 | 30 | $1,252 | $265.89 | 21.2% |
| 81003 | Automated urinalysis test | Office | 2022 | 12 | 12 | $120.00 | $26.40 | 22.0% |
About Dr. Bryan Davis, M.D
Dr. Bryan Davis, M.D is a Family Medicine healthcare provider based in Nacogdoches, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1295760080.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bryan Davis, M.D has received a total of $2,951 in payments from pharmaceutical and medical device companies, with $495.92 received in 2024. These payments were reported across 185 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($2,926).
As a Medicare-enrolled provider, Davis has provided services to 669 Medicare beneficiaries, totaling 1,345 services with total Medicare billing of $90,085. Data is available for 2 years (2022–2023), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Nacogdoches, TX
- Active Since 07/11/2006
- Last Updated 10/07/2014
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1295760080
Products in Payments
- JANUVIA (Drug) $196.39
- JARDIANCE (Drug) $194.18
- Ozempic (Drug) $170.87
- Rybelsus (Drug) $144.63
- Victoza (Drug) $130.19
- TRULICITY (Drug) $127.74
- AVYCAZ (Drug) $125.00
- MOUNJARO (Drug) $94.23
- FARXIGA (Drug) $92.27
- SYMBICORT (Drug) $84.35
- VRAYLAR (Drug) $81.05
- Otezla (Drug) $78.07
- EMGALITY (Drug) $75.56
- VYVANSE (Drug) $65.02
- Xyrem (Drug) $64.79
- Aimovig (Biological) $58.37
- ELIQUIS (Drug) $57.91
- Wegovy (Drug) $52.91
- Edarbi (Drug) $52.71
- MYDAYIS (Drug) $52.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Nacogdoches
Dr. Mark Cline, M.d, M.D
Family Medicine — Payments: $12,124
Family Medicine $12,124
Dr. Kelley Moon, M.d, M.D
Family Medicine — Payments: $9,736
Family Medicine $9,736
Eric Cline, Md, MD
Family Medicine — Payments: $6,904
Family Medicine $6,904
Rachel Cline
Family Medicine — Payments: $6,628
Family Medicine $6,628
Dr. Philip Labarbera, M.d, M.D
Family Medicine — Payments: $5,195
Family Medicine $5,195
Dr. Wilburn Furniss, M.d, M.D
Family Medicine — Payments: $2,314
Family Medicine $2,314